4.6 Review

Advances of blood cell-based drug delivery systems

期刊

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 96, 期 -, 页码 115-128

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2016.07.021

关键词

Blood cell; Erythrocytes; Leukocytes; Platelets; Drug delivery systems

资金

  1. National Natural Science Foundation of China [81977757]
  2. Morning Star Plan of SJTU [AF1700016]

向作者/读者索取更多资源

Blood cells, including erythrocytes, leukocytes and platelets are used as drug carriers in a wide range of applications. They have many unique advantages such as long life-span in circulation (especially erythrocytes), target release capacities (especially platelets), and natural adhesive properties (leukocytes and platelets). These properties make blood cell based delivery systems, as well as their membrane-derived carriers, far superior to other drug delivery systems. Despite the advantages, the further development of blood cell-based delivery systems was hindered by limitations in the source, storage, and mass production. To overcome these problems, synthetic biomaterials that mimic blood cell and nanocrystallization of blood cells have been developed and may represent the future direction for blood cell membrane-based delivery systems. In this paper, we review recent progress of the rising blood cell-based drug delivery systems, and also discuss their challenges and future tendency of development. (C) 2016 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据